Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Biotechnology

Karuna Therapeutics

Bill Meury

Srinath Muppalaneni

Alicia Meli

Frank Truslow

Jackie Cohen

Reilly Decker

Gregg Pratt

Jonathan Rosin

Mia Kelley

Will Kane

Andrew Miller

Troy A. Ignelzi

Stephen Brannan

Karuna Therapeutics' Leadership Team includes Gregg A. Pratt and 14 others.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Karuna Therapeutics

Board of Directors

CEO and Executive Team